Genotype-phenotype single-cell transcriptomics for massive parallel assessment of genetic variants
Tool / method
TP63
Multiplexed assay of variant effect for TP63 missense variants coupled with full-length scRNA-seq (SCRAMseq)
Summary
The authors used a protein multiplexed assay of variant effect (MAVE) to assess about 2,200 missense variants of TP63, a gene in which some variants cause autosomal dominant developmental disorders. The activity of each variant was measured with an optimised fibroblast-to-keratinocyte conversion protocol, and a subset of mutants was validated through multiple orthogonal biochemical and genomic functional assays. To move beyond a predefined assay, they introduce SCRAMseq, which couples the MAVE with full-length scRNA-seq to link genotype to phenotype cell by cell. The platform was validated across different experimental and genetic contexts, with reproducibility and accuracy demonstrated according to the authors.
Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.
Analysis
The immediate diagnostic interest is the functional map of TP63, which could serve as functional evidence for missense variants in this gene, provided it is calibrated on variants of known classification, which the abstract does not report. SCRAMseq remains a research laboratory tool: reading the whole transcriptome rather than a single readout could in principle extend MAVEs to genes without a simple functional assay, but the abstract gives no performance figures.
Analysis by Dr Thibaut Benquey
Why this score?
Clinical impact: 1/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 0/1 · Publication status: 1/1 → Total: 5/10
Keywords
Every Wednesday · Annotated selection · Free · Unsubscribe anytime